Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel + cisplatin concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma
ChiCTR-ONC-11001927Phase 4Completed
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paclitaxel and cisplatin in nasopharyngeal carcinoma (NPC), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoints: Complete response rate of the primary tumor, Overall response rate of the primary tumor and 2 more. Started Aug 2009; status: completed.
02
Drugs
paclitaxelcisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-ONC-11001927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-11001927.